Experimental animals can be made resistant to implantation of syngeneic tumors and induction of tumors by viruses. I n a few studies established tumors were inhibited by immunotherapy. Such results suggest that immunotherapeutic methods might be useful in clinical cancer. I n animals, immunity is us
IMMUNOGENICITY OF MODIFIED TUMOR CELLS IN SYNGENIC HOSTS
✍ Scribed by Morton D. Prager; William C. Gordon; F. Samuel Baechtel
- Book ID
- 114882411
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 816 KB
- Volume
- 276
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Intravenous injection of fluorescein isothiocyanate‐modified syngeneic spleen cells (FITC‐SSC) into mice induced T cell‐independent, anti‐hapten plaque‐forming cell responses. In contrast to the high immunogenicity of FITC‐coupled SSC or bone marrow cells, thymus, lymph node or peritone
## Abstract Components on the surface of MM2 ascites mammary carcinoma cells induce agglutination factors in the serum of syngeneic host C3H/He mice, and bind the factors in vitro. These components have been classified into three groups: MM2‐specific substances, mammary tumor virus (MTV)‐associated